EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Intratumoral CXCL13 + CD160 + CD8 + T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer

Jiawei Wang, Yuan Liang iD, Ao Xue, Jian Xiao, Xinyu Zhao, Shuqing Cao, Pengyu Li, Jiacheng Dong, Yuan Li, Zekuan Xu, Li Yang iD

Journal for ImmunoTherapy of Cancer · 2024-09 · 12 (9) · e009603

DOI: 10.1136/jitc-2024-009603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 06.09.2024. Verfasst von Jiawei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, CD8-Positive T-Lymphocytes, Tertiary Lymphoid Structures, Chemokine CXCL13. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jiangsu Province Capability Improvement Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stage IV gastric cancer is a highly heterogeneous and lethal tumor with few therapeutic strategies. The combination of programmed cell death protein 1 inhibitors and chemotherapy is currently the standard frontline treatment regimen for advanced gastric cancer. Nevertheless, it remains a great challenge to screen the beneficiaries of immunochemotherapy and expand indications for this treatment regimen.

Methods

We conducted a pathological assessment to ascertain the importance of tertiary lymphoid structures based on the tissue samples collected from patients with stage IV gastric cancer (n=15) both prior to and following immunochemotherapy treatment. Additionally, we used spatial (n=10) and single-cell transcriptional analysis (n=97) to investigate the key regulators of tertiary lymphoid structures (TLSs). Multiplex immunofluorescence and image analysis (n=34) were performed to explore the association between tumor-infiltrating CXCL13 + CD160 + CD8 + T cells and TLSs. The relationship between CXCL13 + CD160 + CD8 + T cells and the responsiveness to immunotherapy was also evaluated by multiplex immunofluorescence and image analysis approaches (n=15). Furthermore, we explored the intrinsic characteristics of CXCL13 + CD160 + CD8 + T cells through various experimental techniques, including quantitative reverse transcription-PCR, western blot, and flow cytometry.

Results

We found that responders exhibited higher levels of TLSs and CXCL13 + CD160 + CD8 + T cells in biopsy tissues prior to immunochemotherapy compared with non-responders. Following conversion therapy, responders also had a higher percentage of mature TLSs and a higher number of CXCL13 + CD160 + CD8 + T cells in surgical resections. Moreover, we discovered that vitamin B 6 in CD160 + CD8 + T cells could reduce the ubiquitination modification of HIF-1α by MDM2, thereby attenuating the degradation of HIF-1α. Consequently, this led to the transcriptional upregulation of CXCL13 expression, facilitating the recruitment of CXCR5 + B cells and the formation of TLSs.

Conclusion

The number and maturity of TLSs, along with the extent of CXCL13 + CD160 + CD8 + T-cell infiltration, might function as potential indicators for assessing the effectiveness of immunotherapy in treating gastric malignancies. Furthermore, our research suggests that vitamin B 6 could enhance the secretion of CXCL13 by CD160 + CD8 + T cells by reducing the degradation of HIF-1α. Additionally, we demonstrate that vitamin B 6 supplementation or targeting pyridoxal kinase could substantially improve the efficacy of immunotherapies for gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsCD8-Positive T-LymphocytesTertiary Lymphoid StructuresChemokine CXCL13ImmunotherapyAntigens, CDHumansMaleFemaleMiddle AgedGPI-Linked ProteinsAgedReceptors, ImmunologicTumor MicroenvironmentLymphocytes, Tumor-InfiltratingNeoplasm Staging

Stichwörter der Autor:innen

Gastric CancerImmunotherapyT cell

Substanzen

Chemokine CXCL13CXCL13 protein, humanAntigens, CDCD160 protein, humanGPI-Linked ProteinsReceptors, Immunologic

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Southeast University, Nanjing, Jiangsu, China.
  • Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China pwkyangli@njmu.edu.cn.

ORCID-Profile: Yuan Liang, Li Yang

Förderung

  • Jiangsu Province Capability Improvement Project
  • National Natural Science Foundation of China

Zitieren

APA

Wang, J., Liang, Y., Xue, A., Xiao, J., Zhao, X., Cao, S., Li, P., Dong, J., Li, Y., Xu, Z., & Yang, L. (2024). Intratumoral CXCL13 + CD160 + CD8 + T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer. Journal for ImmunoTherapy of Cancer, 12(9), e009603. https://doi.org/10.1136/jitc-2024-009603

Vancouver

Wang J, Liang Y, Xue A, Xiao J, Zhao X, Cao S, et al. Intratumoral CXCL13 + CD160 + CD8 + T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer. Journal for ImmunoTherapy of Cancer. 2024;12(9):e009603. doi:10.1136/jitc-2024-009603

BibTeX
@article{Wang2024,
  author = {Wang, Jiawei and Liang, Yuan and Xue, Ao and Xiao, Jian and Zhao, Xinyu and Cao, Shuqing and Li, Pengyu and Dong, Jiacheng and Li, Yuan and Xu, Zekuan and Yang, Li},
  title = {Intratumoral CXCL13 + CD160 + CD8 + T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  volume = {12},
  number = {9},
  pages = {e009603},
  doi = {10.1136/jitc-2024-009603}
}
Kostenlos starten →